Latest updates for Bcax

Fresh curated links around BCAX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Bicara Therapeutics (BCAX) Q2 2026 Earnings Call Transcript
  • Baxfendy Approval
  • BioXcel

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fool.com /3 weeks ago

Bicara Therapeutics (BCAX) Q2 2026 Earnings Call Transcript

Cash runway extends to 2029 as ficerafusp alfa advances toward interim analysis.

Read source
cafepharma.com /2 weeks ago

Baxfendy Approval

Baxfendy Approval Anonymous (not verified) Sat, 08/22/2026 - 06:38 field_thread_url https://cafepharma.com/boards/threads/baxfendy-approval.716800/...

Read source
cafepharma.com /1 week ago

BioXcel

BioXcel Anonymous (not verified) Sun, 08/30/2026 - 09:43 field_thread_url https://cafepharma.com/boards/threads/bioxcel.674502/ board na...

Read source
seekingalpha.com /1 month ago

Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions

Read source
seekingalpha.com /1 week ago

BioXcel files for Chapter 11, will sell assets to Teva

Read source
pharmexec.com /1 week ago

<![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...

Read source
seekingalpha.com /1 month ago

ImmunityBio: ANKTIVA's Commercial Momentum Supports A Buy

Read source
seekingalpha.com /3 weeks ago

BioCardia, Inc. (BCDA) Q2 2026 Earnings Call Transcript

Read source
pharmexec.com /1 month ago

<![CDATA[Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million ]]>

Read source
biopharmadive.com /1 month ago

AbCellera, Vertex partner on next-gen T-cell engagers

The deal adds to a growing streak of partnerships involving new types of T cell engagers and gives Vertex another chance to broaden a business still reliant on cystic fibrosis medi...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Bcax

cafepharma.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source